Jesduvroq 4 mg/1 (Daprodustat TABLET, FILM COATED) 4 mg/1

Jesduvroq 4 mg is a medication containing daprodustat, used to manage certain conditions related to anemia. This oral tablet is designed for convenient daily use, offering a targeted approach to support blood health.

Strength

4 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE (0173-0906-13)

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Jesduvroq 4 mg is primarily used to help manage anemia, a condition characterized by a low red blood cell count. Daprodustat, the active ingredient, works by stimulating the production of red blood cells. This medication is often prescribed for individuals who require support in maintaining healthy blood cell levels.

Side Effects

Common effects of Jesduvroq 4 mg may include improvements in energy levels and overall well-being as the body responds to increased red blood cell production. Some users may experience mild side effects, which typically subside as the body adjusts to the medication.

Precautions & Warnings

It is important to handle Jesduvroq 4 mg tablets with care, storing them in a cool, dry place away from direct sunlight. Always follow the guidance provided by your healthcare professional regarding the use of this medication. Avoid sharing your medication with others.

Avoid Interactions

Jesduvroq 4 mg may interact with certain substances, including alcohol and other medications. It is advisable to consult with a healthcare professional before combining this medication with other treatments or supplements. Always inform your healthcare provider about all medications you are currently taking.

Frequently Asked Questions

Jesduvroq 4 mg is used to help manage anemia by stimulating the production of red blood cells.

Jesduvroq 4 mg is taken orally, typically once daily. Follow the instructions provided by your healthcare professional.

Common side effects may include mild gastrointestinal discomfort and headaches, which usually subside as the body adjusts to the medication.

It is advisable to consult with your healthcare professional regarding alcohol consumption while taking Jesduvroq 4 mg.

Store Jesduvroq 4 mg in a cool, dry place away from direct sunlight and out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.